Altitude Crest Partners Inc.

CIK

1986035

Location

Stamford, CT

Portfolio Value

Small $224,601,478

Diversification

Diversified

Filing Date

Global Rank

#4,833 / 7,434 ▲ 1031 · as of Mar 2024

Top Industry

Biotechnology 68.0%

Period ended 2 years ago

Filed May 14, 2024 · 2y

2 quarters · since Dec 2023

Regulatory profile

From Form ADV, the SEC filer profile, 13D/13G type codes and N-CEN, never from the name.

Holder type

Unknown

Portfolio style

Measured from the filed 13F common-share book for Mar 31, 2024, never from the firm's own description.

Style

Concentrated

The top 10 positions are 71.7% of the book (60%+)

Turnover

Turnover unknown

It needs four straight quarters of measured turnover

Horizon

Short horizon

Value-weighted holding period 1.5 quarters (under 4)

Closest benchmark: the S&P 500 as of 2024-03-31, active share 97.7%; sector active share 82.7% against the combined 13F book's sector weights.

Over time 2 measured quarters

How the bands are measured

Style bands measure the filed 13F common-share book each closed quarter, tested in this order. Unknown: under $10,000,000 of valued equity or 5 stocks. Index-like (100+ stocks): active share of 20% or less against the closest benchmark, which is the S&P 500, S&P MidCap 400, S&P SmallCap 600, Russell 1000, Russell 2000, Nasdaq-100 or Dow Jones Industrial Average (weighted by an index-tracking fund's reported holdings or the index's constituents nearest the quarter end, over the names resolved to companies, and only when those are 90%+ of its weight) or every 13F filer's combined book, or index series holding 80%+ of the registered fund assets it advises (N-CEN) and equal to 50%+ of its book. Systematic-like: 500+ stocks, 100%+ annual turnover and a top 10 weight of 25% or less. Concentrated: a top 10 weight of 60%+ or 12 or fewer effective positions. Diversified active: none of these. Turnover is the smaller of buys and sells over average equity value, summed over four quarters: low under 30%, high 100%+. Horizon is the value-weighted number of quarters each position has been held: short under 4, long 12+.

Clone Performance

Build a hypothetical price-return history from this filer's public 13F holdings.

View clone backtest

Portfolio Concentration

29 tracked positions · as of Mar 31, 2024 · Δ vs Dec 31, 2023

Top Position

16.3%

−6.7 pts

Top 5

52.2%

−28.0 pts

Top 10

71.7%

−28.3 pts

HHI

738

Diversified−887

Portfolio Trend

2 quarters · across all stocks

Sector Breakdown

As of Mar 31, 2024

Sector	% Portfolio	Value	Positions
Healthcare	94.2%	$211,547,955	25
Unclassified	5.8%	$13,053,523	4

Last Quarter's Activity

Export CSV

Mar 31, 2024 vs Dec 31, 2023

Added To

Positions the filer increased

2 positions

Ticker	Company	Δ Shares	Shares	Value
—		+135,077	287,277	$16,886,142
LEGN	Legend Biotech Corp	+110,916	652,732	$36,611,737
No positions match the current search.

Trimmed

Positions the filer reduced

3 positions

Ticker	Company	Δ Shares	Shares	Value
ROIV	Roivant Sciences Ltd.	−353,295	454,766	$4,793,233
BBIO	BridgeBio Pharma, Inc.	−142,500	612,060	$18,924,895
DHR	Danaher Corp	−12,900	108,700	$27,144,564
No positions match the current search.

New Positions

Positions the filer opened this quarter

22 positions

Ticker	Company	Shares	Value
STVN	Stevanato Group S.p.A.	550,000	$17,655,000
TMO	Thermo Fisher Scientific Inc.	18,400	$10,694,264
AVBP	ArriVent BioPharma, Inc.	555,555	$9,922,212
GPCR	Structure Therapeutics Inc.	205,166	$8,793,414
JANX	Janux Therapeutics, Inc.	193,300	$7,277,745
LLY	ELI LILLY & Co	9,200	$7,157,232
BHVN	Biohaven Ltd.	118,380	$6,474,202
IMNM	Immunome Inc.	262,284	$6,473,169
—		128,842	$6,341,603
GERN	Geron Corp	1,531,400	$5,053,620
ICLR	Icon PLC	14,800	$4,972,060
—		109,837	$4,945,960
DNLI	Denali Therapeutics Inc.	209,613	$4,301,258
CRBP	Corbus Pharmaceuticals Holdings, Inc.	103,703	$4,069,305
AGIO	Agios Pharmaceuticals, Inc.	113,100	$3,307,044
—		195,497	$3,229,610
ENGN	enGene Therapeutics Inc.	120,289	$2,038,898
—		259,700	$1,765,960
ZYME	Zymeworks Inc.	145,581	$1,531,512
MGX	Metagenomi Therapeutics, Inc.	133,333	$1,406,663
ALNY	Alnylam Pharmaceuticals, Inc.	200	$29,890
—		47,400	$0
No positions match the current search.

Sold Out

Positions the filer fully exited

4 positions

Ticker	Company	Shares	Value
ARGX	Argenx SE	29,500	$11,222,685
BMRN	Biomarin Pharmaceutical Inc	114,042	$10,995,929
—		99,130	$7,333,637
—		43,100	$613,744
No positions match the current search.

Portfolio Positions

Compact Export CSV View 13F filing

29 tracked positions · $224,601,478 total · filing declares 30 positions · $233,587,645 · as of Mar 31, 2024

All sectors Healthcare

Ticker	Company	Type	Shares	Δ Shares	Value (USD)	% Δ Value	Held (qtrs)	Est. cost/share	% of Portfolio
LEGN	Legend Biotech Corp Healthcare	Added	652,732	+110,916	$36,611,737	+12.3%	2	before history	16.30%
DHR	Danaher Corp Healthcare	Reduced	108,700	-12,900	$27,144,564	−3.5%	2	before history	12.09%
BBIO	BridgeBio Pharma, Inc. Healthcare	Reduced	612,060	-142,500	$18,924,895	−37.9%	2	before history	8.43%
STVN	Stevanato Group S.p.A. Healthcare	NEW	550,000	NEW	$17,655,000	NEW	1	$30.44	7.86%
		Added	287,277	+135,077	$16,886,142	+85.3%	2	before history	7.52%
TMO	Thermo Fisher Scientific Inc. Healthcare	NEW	18,400	NEW	$10,694,264	NEW	1	$561.14	4.76%
AVBP	ArriVent BioPharma, Inc. Healthcare	NEW	555,555	NEW	$9,922,212	NEW	1	$20.17	4.42%
GPCR	Structure Therapeutics Inc. Healthcare	NEW	205,166	NEW	$8,793,414	NEW	1	$42.17	3.92%
JANX	Janux Therapeutics, Inc. Healthcare	NEW	193,300	NEW	$7,277,745	NEW	1	$21.78	3.24%
LLY	ELI LILLY & Co Healthcare	NEW	9,200	NEW	$7,157,232	NEW	1	$711.67	3.19%
BHVN	Biohaven Ltd. Healthcare	NEW	118,380	NEW	$6,474,202	NEW	1	$49.52	2.88%
IMNM	Immunome Inc. Healthcare	NEW	262,284	NEW	$6,473,169	NEW	1	$20.29	2.88%
		NEW	128,842	NEW	$6,341,603	NEW	1	unpriced	2.82%
GERN	Geron Corp Healthcare	NEW	1,531,400	NEW	$5,053,620	NEW	1	$2.23	2.25%
ICLR	Icon PLC Healthcare	NEW	14,800	NEW	$4,972,060	NEW	1	$294.81	2.21%
		NEW	109,837	NEW	$4,945,960	NEW	1	unpriced	2.20%
ROIV	Roivant Sciences Ltd. Healthcare	Reduced	454,766	-353,295	$4,793,233	−47.2%	2	before history	2.13%
DNLI	Denali Therapeutics Inc. Healthcare	NEW	209,613	NEW	$4,301,258	NEW	1	$18.79	1.92%
CRBP	Corbus Pharmaceuticals Holdings, Inc. Healthcare	NEW	103,703	NEW	$4,069,305	NEW	1	$24.66	1.81%
AGIO	Agios Pharmaceuticals, Inc. Healthcare	NEW	113,100	NEW	$3,307,044	NEW	1	$26.78	1.47%
		NEW	195,497	NEW	$3,229,610	NEW	1	unpriced	1.44%
ALGS	Aligos Therapeutics, Inc. Healthcare	Held	2,844,681	0	$2,787,787	+47.6%	2	before history	1.24%
ENGN	enGene Therapeutics Inc. Healthcare	NEW	120,289	NEW	$2,038,898	NEW	1	$12.24	0.91%
		NEW	259,700	NEW	$1,765,960	NEW	1	unpriced	0.79%
ZYME	Zymeworks Inc. Healthcare	NEW	145,581	NEW	$1,531,512	NEW	1	$11.10	0.68%
MGX	Metagenomi Therapeutics, Inc. Healthcare	NEW	133,333	NEW	$1,406,663	NEW	1	$11.50	0.63%
ALNY	Alnylam Pharmaceuticals, Inc. Healthcare	NEW	200	NEW	$29,890	NEW	1	$166.82	0.01%
SRZNW	Surrozen, Inc. Healthcare	Held	384,573	0	$12,499	+62.5%	2	before history	0.01%
		NEW	47,400	NEW	$0	NEW	1	unpriced	0.00%

Covers the securities this platform tracks: U.S.-listed common stock and the put/call positions reported on it. A 13F can also report security types outside that coverage — preferred shares, bonds, warrants, untracked share classes — so the filing's own declared total can exceed the figures above. The source filing is linked at the top of this table.